Nephros Inc.
NEPH | NASDAQ
$3.17
-$0.10 (-3.06%)
At close: Oct 30, 2026, 4:00 PM ET
$3.15
-$0.02 (-0.54%)
Pre-market:
Nov 2, 2026, 7:00 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Net Income | 1.19M | 74K | -1.58M | -4.55M | -3.87M | -4.53M |
Depreciation & Amortization | 139K | 137K | 214K | 351K | 252K | 208K |
Stock-Based Compensation | 296K | 153K | 1.05M | 952K | 1.26M | 779K |
Other Working Capital | 646K | -642K | 189K | -450K | -43K | 140K |
Other Non-Cash Items | 429K | 698K | 648K | -213K | 56K | 129K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -413K | -1.55M | 488K | 229K | 883K | -3.49M |
Operating Cash Flow | 1.65M | -492K | 827K | -3.23M | -1.42M | -6.9M |
Capital Expenditures | n/a | -55K | -75K | -137K | -36K | -239K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | 5K | n/a | n/a | -49K | n/a |
Investing Cash Flow | n/a | -50K | -75K | -137K | -85K | -239K |
Debt Repayment | -5K | -5K | -79K | -286K | -264K | -321K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | 157K | n/a | 85K |
Financial Cash Flow | -5K | -5K | -79K | 34K | 237K | 11.22M |
Net Cash Flow | 1.64M | -547K | 673K | -3.34M | -1.28M | 4.08M |
Free Cash Flow | 1.65M | -547K | 752K | -3.37M | -1.45M | -7.14M |
Adj. Free Cash Flow | 1.35M | -700K | -300K | -4.32M | -2.71M | -7.92M |
Maintenance CapEx | n/a | -55K | n/a | -137K | n/a | -239K |
Growth CapEx | n/a | n/a | -75K | n/a | -36K | n/a |
Owner Earnings | 1.65M | -547K | 827K | -3.37M | -1.42M | -7.14M |
Add to Watchlist
Select watchlists to add or remove NEPH